Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew H. Galligan currently holds 250,824 shares of NEVRO CORP (NVRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew H. Galligan has been a net seller of NVRO stock. They have purchased $0 and sold $16.2M worth of shares.
Andrew H. Galligan's most recent insider trade was on Jun 4, 2026, when they sold 9,743 shares at $0.00 per share.
Andrew H. Galligan serves as Executive at NEVRO CORP (NVRO). They have executed 92 insider transactions totaling $16.2M over their tenure at the company.
Andrew H. Galligan holds the position of Executive at NEVRO CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Andrew H. Galligan has shown a selling trading pattern, with $0 in total purchases and $16.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew H. Galligan was on Jan 8, 2020, when they sold $2.1M worth of NVRO shares. This transaction involved 17,718 shares at $120.11 per share.
Andrew H. Galligan currently owns 250,824 shares of NEVRO CORP (NVRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew H. Galligan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew H. Galligan has 92 Form 4 filings on record as an insider at NEVRO CORP.
Set alerts for Andrew H. Galligan and 40,000+ other insiders.